OR WAIT null SECS
ATLANTA, Ga-An advisory committee has narrowly rejected to recommend a combination vaccine for children after questioning the vaccination's immunogenicity.
Infanrix, manufactured by GlaxoSmithKline, was voted down by a 6-5 vote. There was one abstention.
The vaccine is designed to guard against five common childhood diseases: diphtheria, whooping cough, tetanus, hepatitis B, and polio. The panel said the vaccine would not be recommended to the FDA because they questioned its effectiveness in creating a protective immune response.
The advisory panel's decision is not final; although, it is strongly considered by the FDA when approving new drugs.
A spokesperson for GlaxoSmithKline said the company is confident Infanrix would ultimately be approved.